Detalhe da pesquisa
1.
Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted RSV Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled Trial.
Clin Infect Dis
; 2024 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38189778
2.
Adult immunization practices, challenges and opportunities in Central America and the Caribbean: Advisory board proceedings.
Hum Vaccin Immunother
; 18(7): 2129236, 2022 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36469706
3.
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Lancet Infect Dis
; 22(3): 329-340, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34826381
4.
Highlights of an Expert Advisory Board on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) in Latin America.
Int J Chron Obstruct Pulmon Dis
; 15: 1919-1929, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32821094